Steven D. Wexner

PolyPid Strengthens Executive Team, Appointing Dr. Anthony Senagore as Senior Medical Director

Retrieved on: 
Monday, July 12, 2021

I am delighted to welcome Dr. Senagore to the PolyPid team as we continue to advance toward commercialization of D-PLEX100, stated Amir Weisberg, CEO of PolyPid.

Key Points: 
  • I am delighted to welcome Dr. Senagore to the PolyPid team as we continue to advance toward commercialization of D-PLEX100, stated Amir Weisberg, CEO of PolyPid.
  • Anthony J. Senagore, M.D., is a colorectal surgeon with a long track record of academic surgery practice and significant experience in healthcare start-up companies.
  • In addition, Dr. Senagore has edited five textbooks in colon and rectal surgery and authored over 230 peer-reviewed publications and 25 textbook chapters.
  • PolyPid Ltd. (Nasdaq: PYPD ) is a Phase 3 biopharmaceutical company aiming to improve surgical outcomes through locally administered, controlled, extended-release therapeutics.

Ohio State Wexner Medical Center, DispatchHealth Partner On In-Home Medical Care

Retrieved on: 
Tuesday, June 1, 2021

Beginning July 1, Ohio State Wexner Medical Center patients and providers throughout the Columbus community can request DispatchHealth's medical care for a wide range of common to complex injuries and illnesses including viral infections, COPD exacerbations, congestive heart failure and more.

Key Points: 
  • Beginning July 1, Ohio State Wexner Medical Center patients and providers throughout the Columbus community can request DispatchHealth's medical care for a wide range of common to complex injuries and illnesses including viral infections, COPD exacerbations, congestive heart failure and more.
  • Patients can request care by phone, DispatchHealth's mobile app or website, and in the future through Ohio State Wexner Medical Center's website and OSUMyChart.
  • "We are pleased to partner with Ohio State Wexner Medical Center to expand the focus on effective, convenient and affordable care outside of the typical clinic and hospital setting.
  • The Ohio State Wexner Medical Center and DispatchHealth partnership brings a combined focus on continuous improvement of patient health outcomes at a lower cost.

OSU Wexner Medical Center, Battelle Open Door to Using Neurotechnology at Home

Retrieved on: 
Monday, October 12, 2020

The Ohio State University Wexner Medical Center has secured $800,000 in grants to develop with Battelle the NeuroLife interface technology for home use.

Key Points: 
  • The Ohio State University Wexner Medical Center has secured $800,000 in grants to develop with Battelle the NeuroLife interface technology for home use.
  • Thousands of patients come to the medical center each month for treatments and services they cant find anywhere else.
  • Providing access to health care information is central to the medical centers research, education and patient care mission.
  • The Ohio State Wexner Medical Center is dedicated to improving health in Ohio and across the world through innovation in research, education and patient care.